Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gartner (Barcelona, Spain), P. Fernandez-Alvarez (Barcelona, Spain), I. Lima (Barcelona, Spain), S. Rovira (Barcelona, Spain), C. Picado (Barcelona, Spain), E. Garcia-Arumí (Barcelona, Spain), I. De Mir (Barcelona, Spain), A. Torrent (Barcelona, Spain), A. Moreno (Barcelona, Spain), I. Iglesias (Barcelona, Spain), E. Tizzano (Barcelona, Spain). Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations.. 2106

Member's Comments

No comment yet.

Related content which might interest you: Correlation between inflammatory and oxidation markers in adults with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Nutritional intervention in cystic fibrosis Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153 Year: 2003 Inflammatory markers in cystic fibrosis patients with different values of pulmonary function tests Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002 Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 LSC 2010 Abstract: Ceramide is increased and associated with neutrophilic inflammation in the lower airway epithelium of people with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020 Year: 2021 Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase? Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Clinical correlation of epithelial barrier dysfunction related to neutrophilic inflammation in cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis? Source: Breathe 2008; 4: 365 Year: 2008 Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018